BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 23887202)

  • 1. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
    Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
    Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation.
    Kellner S; Weinitz S; Farmand G; Kellner U
    Br J Ophthalmol; 2014 Feb; 98(2):200-6. PubMed ID: 24187053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
    Bhavsar KV; Mukkamala LK; Freund KB
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):377-9. PubMed ID: 25856825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK; Yu M; Weleber RG
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
    Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
    Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal imaging in persistent placoid maculopathy.
    Gendy MG; Fawzi AA; Wendel RT; Pieramici DJ; Miller JA; Jampol LM
    JAMA Ophthalmol; 2014 Jan; 132(1):38-49. PubMed ID: 24310266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G; Tassi D
    Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOXIC EFFECTS OF HYDROXYCHLOROQUINE ON THE CHOROID: Evidence From Multimodal Imaging.
    Ahn SJ; Ryu SJ; Lim HW; Lee BR
    Retina; 2019 May; 39(5):1016-1026. PubMed ID: 29373341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA; Hedges TR; Monson B; Srinivasan V; Wojtkowski M; Reichel E; Duker JS; Schuman JS; Fujimoto JG
    Arch Ophthalmol; 2007 Jun; 125(6):775-80. PubMed ID: 17562988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. En Face Optical Coherence Tomography Imaging of the Photoreceptor Layers in Hydroxychloroquine Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2019 Mar; 199():71-81. PubMed ID: 30448463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.